Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C49H61N9O13 |
| Molecular Weight | 984.063 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CNC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](C)NC(=O)CCCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC4=CC=CC=C4)C(N)=O
InChI
InChIKey=BRUVESZIOCJLDB-GJPUTSFASA-N
InChI=1S/C49H61N9O13/c1-27(2)20-36(47(69)58-39(24-43(64)65)49(71)55-35(44(50)66)21-29-10-5-4-6-11-29)57-48(70)38(23-31-25-51-34-13-8-7-12-33(31)34)54-41(61)26-52-46(68)37(22-30-16-18-32(59)19-17-30)56-45(67)28(3)53-40(60)14-9-15-42(62)63/h4-8,10-13,16-19,25,27-28,35-39,51,59H,9,14-15,20-24,26H2,1-3H3,(H2,50,66)(H,52,68)(H,53,60)(H,54,61)(H,55,71)(H,56,67)(H,57,70)(H,58,69)(H,62,63)(H,64,65)/t28-,35-,36-,37-,38-,39-/m0/s1
Desglugastrin is a gastric acid secretion stimulator. It dose dependently stimulated gastric acid secretion in anaesthetized rats. In view of the trophic action of gastrointestinal hormones on the exocrine pancreas, the effects of desglugastrin on the growth of hamster pancreatic well differentiated adenocarcinoma were investigated in vitro. Desglugastrin exhibited the greatest effect on thymidine incorporation into these cells after a lag period of 96 h. Doses of desglugastrin caused a significant and dose-dependent increase in thymidine incorporation.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2427345
100 ug/kg per hour
Route of Administration:
Intravenous
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C166715
Created by
admin on Wed Apr 02 09:42:26 GMT 2025 , Edited by admin on Wed Apr 02 09:42:26 GMT 2025
|
PRIMARY | |||
|
100000083188
Created by
admin on Wed Apr 02 09:42:26 GMT 2025 , Edited by admin on Wed Apr 02 09:42:26 GMT 2025
|
PRIMARY | |||
|
C062105
Created by
admin on Wed Apr 02 09:42:26 GMT 2025 , Edited by admin on Wed Apr 02 09:42:26 GMT 2025
|
PRIMARY | |||
|
DTXSID201023716
Created by
admin on Wed Apr 02 09:42:26 GMT 2025 , Edited by admin on Wed Apr 02 09:42:26 GMT 2025
|
PRIMARY | |||
|
SUB06994MIG
Created by
admin on Wed Apr 02 09:42:26 GMT 2025 , Edited by admin on Wed Apr 02 09:42:26 GMT 2025
|
PRIMARY | |||
|
43057Q148M
Created by
admin on Wed Apr 02 09:42:26 GMT 2025 , Edited by admin on Wed Apr 02 09:42:26 GMT 2025
|
PRIMARY | |||
|
68687
Created by
admin on Wed Apr 02 09:42:26 GMT 2025 , Edited by admin on Wed Apr 02 09:42:26 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106407
Created by
admin on Wed Apr 02 09:42:26 GMT 2025 , Edited by admin on Wed Apr 02 09:42:26 GMT 2025
|
PRIMARY | |||
|
51987-65-6
Created by
admin on Wed Apr 02 09:42:26 GMT 2025 , Edited by admin on Wed Apr 02 09:42:26 GMT 2025
|
PRIMARY | |||
|
4794
Created by
admin on Wed Apr 02 09:42:26 GMT 2025 , Edited by admin on Wed Apr 02 09:42:26 GMT 2025
|
PRIMARY |
ACTIVE MOIETY